Next Capital Raise (when?), page-63

Possibly Rovira simply misjudged this one. With all the pressos and paid articles pumped out during the last several weeks he was clearly attempting to juice the share price for a raise.

I suspect a combination of underwhelming Oposura assays and general market wariness when it comes to Azure raises (which are rarely value accretive) caused the share price to be far below where he hoped it might be when he ultimately sprung the trap